Thiogenesis Therapeutics, Corp.
TTIPF
$0.44
$0.02897.03%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.89% | -43.64% | -70.17% | -22.57% | 14.84% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.93% | -43.64% | -31.63% | -81.09% | -75.24% |
| Change in Net Operating Assets | -1,084.62% | -235.26% | 92.57% | 321.25% | 108.62% |
| Cash from Operations | -42.90% | -72.18% | -45.01% | -49.22% | -38.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -190.31% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -190.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 112.49% |
| Issuance of Common Stock | -5.93% | -6.14% | -8.26% | -17.52% | 3,970.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.17% | -44.28% | -43.64% | -49.37% | 11,737.18% |
| Foreign Exchange rate Adjustments | 102.69% | 80.55% | 93.19% | 289.66% | -232.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -74.67% | -87.40% | -90.18% | -86.45% | 18.18% |